Filing Details
- Accession Number:
- 0000899243-22-013115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-01 16:30:19
- Reporting Period:
- 2022-03-30
- Accepted Time:
- 2022-04-01 16:30:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861400 | Carol Walker | C/O Lantheus Holdings, Inc. 331 Treble Cove Road North Billerica MA 01862 | Senior Vice President, Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-30 | 15,000 | $56.22 | 64,899 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2022.
Billionaire Hedge Funds
